Table 2.
Peptide | Amino acid sequence | Type | Target | Reference |
---|---|---|---|---|
Anti-gp120 | DGGNSNNESEIFRPGGGDMRDN | Entry inhibitor | HIV-1/gp120 | [162] |
Anti-CCR5 | YQVSSPIYDINYYTSEPCQKINVKQIAA | Entry inhibitor | Co-receptor CCR5 | [163] |
PIE12-trimer | HPXXCDYPEWQWLCXXELGK | Entry inhibitor | HIV gp41 N-trimer pocket | [159] |
GTKWLTEWIPLTAEAEC | RT inhibitor | HIV-1 RT | [179] | |
G12 | GI-p-benzoylphenylalanine-FVSL | Protease inhibitor | ε-amino group of Lys 14 of HIV protease | [205] |
E1P47 | WILEYLWKVPFDFWRGV | Entry inhibitor | HIV-1 Fusion Peptide | [168] |
p7 | KETWETWWTE | RT inhibitor | Dimerization of RT | [182] |
Apam (2)-Tyr-Glu-T (4)-OH | RT inhibitor | HIV-1 protease dimer interface | [180] | |
Vpr 57-71 | VEAIIRILQQLLFIH | RT inhibitor | HIV-1 IN & RT | [183] |
Vpr 61-75 | IRILQQLLFIHFRIG | RT inhibitor | HIV-1 IN & RT | [183] |
NYAD-1 | HITFEDLLDYYGP-NH2 | Gag inhibitor | HIV-1 Gag polyprotein | [245] |
Vif peptide | LITPKKIKPPLPSVT | Vif inhibitor | HIV-1 Vif | [234] |
p27 | PQITLRKKRRQRRRPPQVSFNFCTLNF | Protease inhibitor | WT & PI resistant HIV-1 protease | [190], [207] |
Tetrameric peptide 10 | ((ILPWKWPWWPWPP)2K)2K-NH2 | Integrase inhibitor | HIV-1 integrase | [270] |
Tetrameric RIN-25 | ((ILPWKWPWWPWPP)2K)2K | Integrase inhibitor | HIV-1 integrase | [209] |